SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Pharming says Fabrice Chouraqui will step down as CEO effective immediately

The board appointed Leverne Marsh and Kenneth Lynard as interim co-CEOs effective immediately.

PHAR.AS

V. said on Sept 29 that Fabrice Chouraqui will step down as chief executive officer and executive director with immediate effect. The board has appointed Leverne Marsh, chief commercial officer, and Kenneth Lynard, chief financial officer, as interim co-CEOs, effective immediately. Contact: +48 58 7785110.